Bluebird Bio (BLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BLUE | AMGN | GILD | CELG | VRTX |
| Company | Bluebird Bio | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 60.66 | 239.21 | 68.09 | 108.01 | 268.29 |
| High | 61.34 | 240.06 | 68.82 | 108.59 | 269.95 |
| Low | 59.30 | 238.62 | 68.00 | 107.27 | 265.80 |
| Last | 59.67 | 239.71 | 68.50 | 108.24 | 267.29 |
| Change | -1.23 | -0.75 | +0.32 | +0.11 | +0.14 |
| % Change | -2.02% | -0.31% | +0.47% | +0.10% | +0.05% |
| Volume | 737,500 | 1,224,900 | 9,169,200 | 191,230,500 | 1,008,400 |
| 20-Day Average Volume | 737,010 | 1,974,460 | 8,855,345 | 16,188,930 | 1,362,535 |
| Previous Close | 60.90 | 240.46 | 68.18 | 108.13 | 267.15 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 63.48 | 246.70 | 71.77 | 108.17 | 277.61 |
| 20-Day Raw Stochastic | 4.07% | 18.80% | 5.26% | 63.25% | 14.03% |
| 20-Day Relative Strength | 43.88% | 46.92% | 38.44% | 64.69% | 43.35% |
| Weighted Alpha | -41.10 | +16.50 | +3.10 | +46.30 | +39.60 |
| Today's Opinion | 56% Sell | 56% Buy | 40% Sell | 100% Buy | 24% Buy |
| Previous Opinion | 48% Sell | 56% Buy | 40% Sell | 100% Buy | 24% Buy |
| Last Month's Opinion | 8% Buy | 100% Buy | 72% Buy | 100% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.00% since 08/07/20 | -0.41% since 08/07/20 | -1.23% since 08/07/20 | -1.97% since 11/13/19 | -2.09% since 08/07/20 |
| Low | 59.30 on 08/14/20 | 234.36 on 08/11/20 | 67.92 on 08/11/20 | 107.27 on 11/20/19 | 261.30 on 08/11/20 |
| High | 66.12 on 08/10/20 | 243.00 on 08/12/20 | 69.25 on 08/10/20 | 110.53 on 11/14/19 | 272.73 on 08/13/20 |
| 1-Month | |||||
| %Chg | -5.03% since 07/14/20 | -5.29% since 07/14/20 | -11.26% since 07/14/20 | +5.14% since 10/18/19 | -9.03% since 07/14/20 |
| Low | 59.30 on 08/14/20 | 234.36 on 08/11/20 | 67.92 on 08/11/20 | 102.40 on 10/21/19 | 261.30 on 08/11/20 |
| High | 68.39 on 08/06/20 | 262.82 on 07/20/20 | 78.94 on 07/20/20 | 110.70 on 11/13/19 | 304.00 on 07/20/20 |
| 3-Month | |||||
| %Chg | +10.38% since 05/14/20 | +0.73% since 05/14/20 | -11.30% since 05/14/20 | +13.63% since 08/20/19 | -3.51% since 05/14/20 |
| Low | 53.00 on 05/15/20 | 213.86 on 06/15/20 | 67.92 on 08/11/20 | 93.41 on 08/23/19 | 254.41 on 05/27/20 |
| High | 72.50 on 06/05/20 | 264.97 on 07/06/20 | 79.31 on 06/08/20 | 110.70 on 11/13/19 | 306.08 on 07/07/20 |
| 6-Month | |||||
| %Chg | -33.19% since 02/14/20 | +7.26% since 02/14/20 | +1.39% since 02/14/20 | +14.14% since 05/20/19 | +9.63% since 02/14/20 |
| Low | 38.95 on 03/17/20 | 177.05 on 03/23/20 | 64.41 on 03/16/20 | 89.08 on 07/23/19 | 197.47 on 03/18/20 |
| High | 89.31 on 02/18/20 | 264.97 on 07/06/20 | 85.97 on 03/19/20 | 110.70 on 11/13/19 | 306.08 on 07/07/20 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,032,980 | 140,835,968 | 85,478,904 | 77,035,920 | 69,583,760 |
| Shares Outstanding, K | 66,223 | 585,694 | 1,253,724 | 711,714 | 260,467 |
| Annual Sales | 44,670,000 | 23,362,000,000 | 22,449,000,000 | 15,281,000,000 | 4,162,820,000 |
| Annual Net Income | -789,610,000 | 7,842,000,000 | 5,386,000,000 | 4,046,000,000 | 1,176,810,000 |
| Last Quarter Sales | 198,890,000 | 6,206,000,000 | 5,143,000,000 | 4,520,000,000 | 1,524,490,000 |
| Last Quarter Net Income | -21,470,000 | 1,803,000,000 | -3,339,000,000 | 1,691,000,000 | 837,270,000 |
| 60-Month Beta | 2.32 | 0.92 | 0.64 | 1.41 | 0.88 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.36 on 08/05/20 | 4.25 on 07/28/20 | 1.11 on 07/30/20 | 2.99 on 10/31/19 | 2.61 on 07/30/20 |
| Latest Earnings Date | 08/06/20 | 07/28/20 | 07/30/20 | 10/31/19 | 07/30/20 |
| Most Recent Dividend | N/A | 1.600 on 08/14/20 | 0.680 on 06/11/20 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/14/20 | 09/14/20 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.38 | 12.43 | 10.99 | 39.37 |
